Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.95+0.06 (+7.26%)
Close on Nov 18, 2026Market cap $94.80MP/E –Yield –
Stereotaxis operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Stereotaxis's operating income for the twelve months ending Jun 30, 2026 was -$22.76M. For fiscal 2025 it was -$22.11M. The highest annual figure on record is -$2.46M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.11M | – |
| FY2024 | Dec 31, 2024 | -$24.74M | – |
| FY2023 | Dec 31, 2023 | -$21.84M | – |
| FY2022 | Dec 31, 2022 | -$18.78M | – |
| FY2021 | Dec 31, 2021 | -$12.89M | – |
| FY2020 | Dec 31, 2020 | -$6.71M | – |
| FY2019 | Dec 31, 2019 | -$4.83M | – |
| FY2018 | Dec 31, 2018 | -$2.46M | – |
| FY2017 | Dec 31, 2017 | -$5.92M | – |
| FY2016 | Dec 31, 2016 | -$6.43M | – |
| FY2015 | Dec 31, 2015 | -$5.41M | – |
| FY2014 | Dec 31, 2014 | -$5.38M | – |
| FY2013 | Dec 31, 2013 | -$8.84M | – |
| FY2012 | Dec 31, 2012 | -$10.63M | – |
| FY2011 | Dec 31, 2011 | -$31.94M | – |
| FY2010 | Dec 31, 2010 | -$18.96M | – |
| FY2009 | Dec 31, 2009 | -$23.84M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.57M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.98M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.65M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.56M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.63M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.35M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.02M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.75M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.28M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.62M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.46M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.18M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.35M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.62M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.39M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.53M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.56M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.92M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.05M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.19M | – |
| Q3 FY2019 | Sep 30, 2019 | -$41.21K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.46M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.14M | – |
| Q4 FY2018 | Dec 31, 2018 | -$586.68K | – |
| Q3 FY2018 | Sep 30, 2018 | -$113.78K | -167.8% |
| Q2 FY2018 | Jun 30, 2018 | -$626.06K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.13M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.75M | – |
| Q3 FY2017 | Sep 30, 2017 | $167.80K | – |
| Q2 FY2017 | Jun 30, 2017 | -$434.78K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.90M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.13M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.17M | – |
See a number that looks wrong?